Nulojix Injection, Powder, Lyophilized, For Solution
Product Images NDC 0003-0371

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nulojix (NDC 0003-0371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

This is a chart showing the Mean Calculated GFR (glomerular filtration rate) along with 95% confidence intervals for patients who have undergone kidney transplantation. The data is presented for patients who were either treated with NULOJIX or Cyclosporine. The chart shows the GFR values for different time intervals in months.*

FDA Label Image

Figure 2 (Figure2)

This text displays the mean calculated GFR values with their confidence intervals for two groups of patients, NULOJIX and Cyclosporine, who underwent randomization and transplantation procedures. The values are presented in a graph format across a period of several months.*

FDA Label Image

Nulojix-250mgvial-carton (Nulojix 250mgvial Carton)

The text refers to Nulojix medication, specifically mentioning the drug's name, dose, and administration route. It also provides information about the packaging and reconstitution of the medication. However, due to missing and unreadable characters, the text is not entirely clear and useful.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.